Product Information

LITHIUM CARBONATE 150 MG CAP is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0877 per EA under NDC 00054852625. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LITHIUM CARBONATE 150 MG CAP

Lithium Carbonate
$0.0877per EA

Strength

150 mg/1

NDC

00054852625

Classification

Generic

Dosage Form

CAPSULE, GELATIN COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LITHIUM CARBONATE

Approval Type

New Drug (NDA)

FDA Application

NDA017812

FDA Approved

Before 1982

TE Code

AB

On Market Since

1/28/1987

Pharmacological Classes

Price Statistics

The NADAC for LITHIUM CARBONATE 150 MG CAP has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 33.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0877 per EA
All-time high$0.1032 (Jan 10, 2024)
All-time low$0.0499 (Nov 18, 2015)
52-week high$0.0896
52-week low$0.0847
Median price$0.0784
Average price$0.0769
Largest weekly change+27.7% (Dec 23, 2015)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+0.9%

1M

+0.9%

3M

-2.2%

6M

+0.4%

1Y

-0.3%

3Y

-10.2%

5Y

+19.3%

All

+33.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LITHIUM CARBONATE 150 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE 150 MG CAP, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0877 per EA (NDC 00054852625), effective Aug 19, 2026.

How has the price of LITHIUM CARBONATE 150 MG CAP changed over time?

Over the history we have for it, the NADAC for LITHIUM CARBONATE 150 MG CAP has risen 33.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE 150 MG CAP?

Since Nov 28, 2013, the NADAC for LITHIUM CARBONATE 150 MG CAP has ranged from a low of $0.0499 (Nov 18, 2015) to a high of $0.1032 (Jan 10, 2024), with a median of $0.0784 per EA.

Are there cheaper alternatives to LITHIUM CARBONATE 150 MG CAP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LITHIUM CARBONATE 150 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures LITHIUM CARBONATE 150 MG CAP?

LITHIUM CARBONATE 150 MG CAP (NDC 00054852625) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.